BAM15 is a synthetic mitochondrial uncoupler being studied for its ability to increase energy expenditure, reduce fat mass,
and improve metabolic health. Unlike traditional stimulants, BAM15 acts directly on the mitochondria, increasing proton leak across
the inner mitochondrial membrane and thereby raising energy expenditure without increasing physical activity or food intake.
Early research suggests potential benefits for obesity, metabolic syndrome, and aging, but BAM15 remains experimental and is not FDA-approved for medical use.
How It Is Used in Research Settings
- Studied in obesity research for reducing fat mass by enhancing mitochondrial energy expenditure.
- Investigated for improving glucose tolerance and insulin sensitivity in type 2 diabetes models.
- Explored in aging studies for its potential to improve mitochondrial function and reduce metabolic decline.
- Examined for protective effects against non-alcoholic fatty liver disease (NAFLD) and related metabolic disorders.
Proposed Uses (Research Areas)
- Obesity and weight management research.
- Type 2 diabetes and insulin resistance models.
- Mitochondrial health and aging studies.
- Liver disease (NAFLD/NASH) research.
How It Is Dosed in Research Settings
- Oral (Preclinical Models): Animal studies have investigated doses ranging from 50–200 mcg/kg/day.
- Human data: No established human dosing protocols currently exist; all information is preclinical.
- Cycle length: Preclinical studies typically last 2–8 weeks to assess metabolic and fat loss outcomes.
- Handling: Supplied as research compound powder; stored in controlled conditions per lab protocols.
Important Considerations
- Regulatory status: BAM15 is not FDA-approved; all applications remain preclinical and experimental.
- Evidence base: Current data is limited to animal models, with no human clinical trials published to date.
- Safety: Preclinical studies suggest it does not increase food intake or body temperature, unlike older uncouplers.
However, long-term safety in humans is unknown, and potential risks include mitochondrial dysfunction and organ stress at high doses.
Disclaimer
This material is provided for educational purposes only and summarizes published research on BAM15.
It is not medical advice. BAM15 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.
This compound is for research use only.